The drug discovery and development company Mission Therapeutics Ltd has announced that Colin Goddard will join its board of directors.
A former chief executive of OSI Pharmaceuticals Inc, Dr Goddard obtained a PhD in cancer pharmacology from the University of Aston in Birmingham, UK. He currently serves as executive chairman of US-based Coferon Inc and Merganser Biotech Inc, and as a director on the boards of Endocyte Inc and PanOptica Inc.
Mission Therapeutics announced the appointment on 1 July 2015.
Copyright 2015 Evernow Publishing Ltd